Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
Merck (MRK) Gets FDA Approval for New PAH Drug Winrevair
09:41am, Wednesday, 27'th Mar 2024
Merck's (MRK) Winrevair becomes the first novel activin signaling inhibitor approved by the FDA to treat PAH.
Merck shares rise on FDA approval for Winrevair
06:06pm, Tuesday, 26'th Mar 2024
Merck shares gain 5% to $131.90 in afterhours trading following approval of its new drug for a potentially fatal lung disease.
FDA approves Merck's drug for rare, deadly lung condition
05:11pm, Tuesday, 26'th Mar 2024
The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of market exclusivity.
US FDA approves Merck's blood pressure therapy
05:11pm, Tuesday, 26'th Mar 2024
The U.S. FDA on Tuesday approved Merck's treatment for adults with high blood pressure due to constriction of lung arteries, adding another potential blockbuster drug to the pharmaceutical giant's por
Merck's $11.5 Billion Bet on Its Next Big Drug Finally Arrives
05:07pm, Tuesday, 26'th Mar 2024
The newly approved drug, which treats potentially fatal pulmonary arterial hypertension, is estimated to ring up as much as $7.5 billion in yearly sales.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Tuesday, 26'th Mar 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
2 More Potential Biotech Buyout Targets
01:07pm, Monday, 25'th Mar 2024
M&A activity in the biotech/biopharma sector is expected to remain active due to significant cash on Big Pharma's balance sheets, key patent expirations, and declining revenue from Covid related produ
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
11:31am, Friday, 22'nd Mar 2024
Merck's attempt to use the Keytruda-Lynparza combination in certain non-small cell lung cancer patients has come up short with a second pivotal study failure.
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
09:45am, Thursday, 21'st Mar 2024
Medtronic and Merck are innovative healthcare leaders. Both are developing new products to keep sales growing.
Merck (MRK) Laps the Stock Market: Here's Why
06:56pm, Wednesday, 20'th Mar 2024
Merck (MRK) concluded the recent trading session at $123.85, signifying a +1.35% move from its prior day's close.
Merck's cervical cancer therapy met main goal in late-stage study
07:26am, Friday, 15'th Mar 2024
Merck said on Friday its drug Keytruda, in combination with chemoradiotherapy, met the main goal in a late-stage study in newly diagnosed patients with high-risk locally advanced cervical cancer.
Merck (MRK) Falls More Steeply Than Broader Market: What Investors Need to Know
06:51pm, Thursday, 14'th Mar 2024
Merck (MRK) concluded the recent trading session at $120.51, signifying a -1.35% move from its prior day's close.
Here's Why Merck (MRK) Fell More Than Broader Market
06:56pm, Wednesday, 13'th Mar 2024
Merck (MRK) concluded the recent trading session at $122.16, signifying a -0.41% move from its prior day's close.
7 Dow Darlings for Investors to Buy for March Market Madness
03:30pm, Wednesday, 13'th Mar 2024
The month of March has a reputation for being among the more volatile ones for the stock market. The NCAA basketball tournament known as March Madness also occurs during the month.
Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?
10:05am, Wednesday, 13'th Mar 2024
Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
